BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 38 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,400,000 | -44.6% | 2,500,000 | -54.5% | 0.01% | -47.6% |
| Q2 2023 | $4,332,448 | +6.3% | 5,500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $4,075,500 | +6.5% | 5,500,000 | -35.3% | 0.02% | -25.0% |
| Q4 2022 | $3,825,000 | -24.9% | 8,500,000 | 0.0% | 0.03% | -9.7% |
| Q3 2022 | $5,090,000 | -12.5% | 8,500,000 | -19.0% | 0.03% | +10.7% |
| Q2 2022 | $5,815,000 | -13.4% | 10,500,000 | -8.7% | 0.03% | +55.6% |
| Q1 2022 | $6,716,000 | -32.5% | 11,500,000 | -14.8% | 0.02% | +5.9% |
| Q4 2021 | $9,952,000 | -28.0% | 13,500,000 | +35.0% | 0.02% | -37.0% |
| Q3 2021 | $13,822,000 | -24.0% | 10,000,000 | -9.1% | 0.03% | -50.0% |
| Q1 2021 | $18,198,000 | – | 11,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |